Definium Therapeutics Inc. Common Shares vs KraneShares Electric Vehicles and Future Mobility — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.09 (market cap $4.59B), while KraneShares Electric Vehicles and Future Mobility trades at $27.56 (market cap $72.36M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 63.4× KraneShares Electric Vehicles and Future Mobility's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and KraneShares Electric Vehicles and Future Mobility for 46 Days on average.
| DFTX | KARS | |
|---|---|---|
Market Cap | $4.59B | $72.36M |
Volume | 2,103,937 | 5,034 |
Sector | Health | Sector/Thematic |
52-Week High | $48.45 | $38.01 |
52-Week Low | $10.68 | $27.25 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $3.55B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →